Max Trigger

Natural health product licensed in Canada

Other names

BioXgenic Alpha, BioXgenic Bio Hard, BioXgenic BioTest, MD Science Lab Max Trigger, Swiss Navy Magnum, Swiss Navy TestoX

Licence holder

M.D Science Lab LLC

NPN or DIN-HM

80082941

Status

Active licence

Licence date

7 February 2018

Revision date

10 April 2018

Form

Comprimé

Route of administration

Orale

Application type

Non traditionnelle

If this product were sold in France

• Conditions légales

  Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Tribulus terrestris L.: Les parties de plantes doivent être cuites

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Non-medicinal ingredients

Phosphate de dicalcium dihydraté, Stéarine de palme, Silice, Glaçure pharmaceutique, Cellulose microcristalline, Croscarmellose de sodium, Stéarate de magnésium

Recommended doses in Canada

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to support emotional aspects of sexual health. Contains tribulus which is traditionally used in Ayurveda as aphrodisiac for men. Helps to promote testosterone production in men. Helps support men's healthy sexual interest. Helps to maintain normal function of the thyroid gland. Helps to enhance cognitive function in adults. Helps to support peripheral circulation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

• Contre-indications

  If you have a liver deficiency, do not use this product. If you have hypotension, do not use this product. Do not use if you are diagnosed with breast cancer or prostate cancer, diabetes mellitus, heart disease, kidney disease, liver disease, or sleep apnea. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.

• Effets indésirables connus

  Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Diuretic effect may occur.

• Précautions et mises en garde

  Do not use if you are pregnant or breastfeeding. If you are taking prescription medications, such as but not limited to antidepressants, blood thinners, heart or high blood pressure meditations such as propranolol, medications for diabetes or seizure, consult a health care practitioner prior to use. If you have high blood pressure or if you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a healthcare practitioner prior to use. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer. If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. People with health conditions should consult a health care practitioner before consuming this product. Consult a health care practitioner prior to use if you have benign prostate hypertrophy. Adult women: consult a healthcare practitioner if you experience abnormal hair growth. Consult a health care practitioner prior to use if you have been diagnosed with hypoactive sexual disorder, sexual dysfunction or erectile dysfunction.

Source

Official Health Canada record, licence 80082941

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 10 April 2018 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2018. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.